l 30

L 30 is a blocker of the sodium channel.

PD-1/PD-L1-IN-30 是一种 PD-1/PD-L1结合抑制剂，IC50值为 0.018 μM。PD-1/PD-L1-IN-30 可用于癌症及其他相关疾病的研究。

exo-α-Arabinosidase, Rhodanobacter ginsenosidimutans Gsoil 3054T (EC.3.2.1.55) 是一种糖苷水解酶。

PEG300 (Polyethylene glycol 300) 是一种由乙二醇重复单元形成的聚合物，具有水溶性、低免疫原性和生物相容性。PEG300 是一种分子量为300的中性聚合物。

Moxidectin (CL301423) 是可用于预防和控制心丝虫和蛔虫的一种驱虫剂。

Besifloxacin Hydrochloride (BOL-303224-A) 是一种氟喹诺酮类抗生素。

Levoleucovorin Calcium (CL307782) 是一种亚叶酸的钙盐，在癌症化疗中用作辅助剂。

Homo-PROTAC pVHL30 degrader 1 是一种基于 PROTAC 的 pVHL30 降解剂。

ML303 是吡唑并吡啶流感病毒非结构蛋白 1 的一种拮抗剂，IC90值为 155 nM。它对流感病毒H1N1亚型的EC50值为0.7 μM。

(S)-Mapracorat is a selective and less active agonist of glucocorticoid receptor.

Mapracorat（ZK-245186，BOL-303242X）是一种选择性糖皮质激素受体（glucocorticoid receptor）激动剂，常用作抗炎药，可用于特应性皮炎、白内障术后炎症、过敏性结膜炎。

BAL30072 shows MIC90 values of 4 μg/mL for MDR Acinetobacter spp. and 8 μg/mL for MDR P. aeruginosa, respectively[1][2]. BAL-30072, a siderophore sulfactam, is a monocyclic beta-lactam antibiotic, with activity against multiresistant gram-negative bacilli

Rociletinib hydrobromide is an orally delivered inhibitor of the mutant form of EGFR kinase (Kis: 21.5 nM and 303.3 nM for EGFR L858R/T790M and EGFR WT).

ML307是一种有效的Ubc13酶活性首创抑制剂，IC50为781 nM，具有在免疫调节和炎症研究中的潜力。

Rociletinib (CNX-419) 是一种可口服的EGFR 抑制剂，能够抑制 EGFRL858R/T790M 和 EGFRWT 的活性，IC50值分别为 21.5 nM 和 303.3 nM。

BMS-354326 is a bio-active chemical.

ML-309 is an inhibitor of mutant isocitrate dehydrogenase 1 (IDH1). It reversibly and selective inhibits IDH1R132H over wild-type IDH1 (IC50s = 96 and 36,500 nM, respectively). ML-309 reduces 2-hydroxyglutarate production in U87 MG glioblastoma cells (EC50 = 55 nM).

CPL304110 是一种口服具有活力的、选择性的、有效的成纤维细胞生长因子受体 FGFR (1-3) 的抑制剂，能够作用于 FGFR1 (IC50: 0.75 nM)、 FGFR2 (IC50: 0.5 nM)、FGFR3 (IC50: 3.05 nM) 。

PP2 Analog is an analog of PP2. It also acts as a protein trafficking modulator.

Licofelone (ML-3000) 是一种 COX/LOX 双重抑制剂，IC50分别为 0.21和0.18 μM，有潜力研究骨关节炎，具有抗炎和抗增殖作用。它可诱导细胞凋亡，减少促炎性白三烯和前列腺素的产生。

CEP-11981是一种具有口服活性的TIE2/泛VEGFR抑制剂，具有广泛的酪氨酸激酶抑制活性，能够抗肿瘤和抗血管生成，可用于难治性实体瘤。

Difenamizole HCl is the salt form of Difenamizole, a non-steroidal anti-inflammatory drug (NSAID) and analgesic of the pyrazolone group related to metamizole. It has monoaminergic properties, including inhibition of monoamine oxidase, augmentation of pargyline-induced elevation of striatal dopamine levels, inhibition of K+-induced striatal dopamine release, and inhibition of the reuptake of dopamine.

IU2-6 is an USP14 inhibitor.

ML309 is a potent inhibitor of R132H mutant IDH1 capable of reducing 2-hydroxyglutarate production in U87 MG glioblastoma cells. ML309 is capable of potent and selective inhibition of mutant IDH1 and effectively lowers cell-based production of 2-HG in a U87MG mutant glioblastoma cell line.